Laboratory evaluation of different agar media for isolation of carbapenem-resistant Acinetobacter spp.

被引：8
作者：
Moran-Gilad, J. [1 ]
Adler, A. [2 ]
Schwartz, D. [3 ]
Navon-Venezia, S. [2 ,4 ]
Carmeli, Y. [2 ]
机构：
[1] Minist Hlth, Publ Hlth Serv, Jerusalem, Israel
[2] Minist Hlth, Natl Ctr Infect Control, Tel Aviv, Israel
[3] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Clin Microbiol Lab, IL-69978 Tel Aviv, Israel
[4] Ariel Univ, Dept Mol Biol, Ariel, Israel
来源：
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 2014年 / 33卷 / 11期
关键词：
BAUMANNII-CALCOACETICUS COMPLEX; CRITICALLY-ILL PATIENTS; CHROMAGAR ACINETOBACTER; SURVEILLANCE CULTURES; CARRIAGE;
D O I：
10.1007/s10096-014-2159-y
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
The optimal method for surveillance of carbapenem-resistant Acinetobacter spp. (CRAB) is unknown. A collection of CRAB strains (n = 42), carbapenem-susceptible strains (CSAB), and non-Acinetobacter strains (n = 18) was used to evaluate six laboratory surveillance methods: MacConkey (MAC), MAC + 1 mu g/ml imipenem (MAC-IPM), minimal salts agar + 1 % acetate (MSA), MSA with IPM disk (MSA-IPM), CHROMagarKPC, and CHROMagar Acinetobacter with CR102 (CHROMAcineto). CHROMAcineto was 100 % sensitive and specific. CHROMagarKPC and MAC-IPM were highly sensitive (> 95 %), but their specificity was substantially hampered by the breakthrough growth of CSAB. MSA was unsuitable for CRAB detection. CHROMAcineto is a promising medium for CRAB detection and warrants further clinical evaluation.
引用
收藏
页码：1909 / 1913
页数：5
相关论文
共 13 条
  • [1] Laboratory and Clinical Evaluation of Screening Agar Plates for Detection of Carbapenem-Resistant Enterobacteriaceae from Surveillance Rectal Swabs
    Adler, Amos
    Navon-Venezia, Shiri
    Moran-Gilad, Jacob
    Marcos, Evgeniya
    Schwartz, David
    Carmeli, Yehuda
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (06) : 2239 - 2242
  • [2] Comparison of culture media for detection of Acinetobacter baumannii in surveillance cultures of critically-ill patients
    Ajao, A. O.
    Robinson, G.
    Lee, M. S.
    Ranke, T. D.
    Venezia, R. A.
    Furuno, J. P.
    Harris, A. D.
    Johnson, J. K.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (11) : 1425 - 1430
  • [3] CHROMagar Acinetobacter is not selective for carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex
    Akers, Kevin S.
    Barsoumian, Alice
    Beckius, Miriam L.
    Murray, Clinton K.
    Mende, Katrin
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2010, 67 (02) : 209 - 211
  • [4] Variations of CHROMagar Acinetobacter to detect imipenem-resistant Acinetobacter baumannii-calcoaceticus complex
    Barsoumian, Alice
    Calvano, Tatjana
    Markelz, Ana E.
    Cassidy, Ryan
    Murray, Clinton K.
    Beckius, Miriam L.
    Mende, Katrin
    Akers, Kevin S.
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 45 (06) : 446 - 452
  • [5] Distribution of Acinetobacter species on skin of healthy humans
    Berlau J.
    Aucken H.
    Malnick H.
    Pitt T.
    [J]. European Journal of Clinical Microbiology and Infectious Diseases, 1999, 18 (3) : 179 - 183
  • [6] Clinical and Laboratory Standards Institute, 2004, M22A3 CLSI
  • [7] Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI
  • [8] Treatment options for multidrug-resistant Acinetobacter species
    Gilad, Jacob
    Carmeli, Yehuda
    [J]. DRUGS, 2008, 68 (02) : 165 - 189
  • [9] Evaluation of CHROMagar Acinetobacter for Detection of Enteric Carriage of Multidrug-Resistant Acinetobacter baumannii in Samples from Critically Ill Patients
    Gordon, N. C.
    Wareham, D. W.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (07) : 2249 - 2251
  • [10] Health Protection Agency, 2008, WORK PART GUID CONTR
12